← Back
Data updated: Mar 10, 2026
MIRUM
GastroenterologyInfectious Disease
MIRUM is a pharmaceutical company focused on Gastroenterology, Infectious Disease. Key products include CHOLBAM.
2015
Since
3
Drugs
-
Trials
7
Approved (2yr)
Key Drugs
Recent Activity
LIVMARLI 2025-04-10
Type 3 - New Dosage Form
CTEXLI 2025-02-21
Type 5 - New Formulation or New Manufacturer
LIVMARLI 2024-11-08
Labeling
LIVMARLI 2024-07-24
Efficacy
LIVMARLI 2024-07-24
Manufacturing (CMC)
LIVMARLI 2024-03-13
Efficacy
LIVMARLI 2024-03-13
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 61%
1 drugs Phase 3: 3 Phase 2: 2
Infectious Disease 39%
0 drugs Phase 3: 2 Phase 2: 2 Phase 1: 2
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Infectious Disease, Gastroenterology
Bristol-Myers Squibb big-pharma
Gastroenterology, Infectious Disease
APOTHECON specialty
Infectious Disease, Gastroenterology
Gilead Sciences biotech
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Infectious Disease, Gastroenterology